slides · global inventory
Development
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,188
Current window 8,401-8,430
Pages 373
Rows per page 30
Beat
8,401-8,430 of 11,188
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
10
The slide uses a side-by-side comparison table structure to contrast two business segments.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
11
Includes footnotes regarding definitions of working capital and gross debt.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
12
The table tracks various operational and market factors, noting whether the outlook is consistent with previous quarters.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
13
Includes specific footnotes regarding depreciation, share counts, and inventory cost impacts.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
05
BenevolentAI | Investor Conference Presentation Deck | 17 slidesBenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
The slide uses a split-screen approach to contrast pre-clinical efficiency with clinical efficacy improvements.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a process flow diagram to illustrate the company's core technology stack.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Industry benchmarks based on Paul et al Nat Rev Drug Discov 2010.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
The slide uses a two-part structure to categorize product updates into 'New Content' and 'New Functionality', illustrated with mobile app screenshots.DraftKings | Results Presentation Deck | 12 slides · DraftKings
Conference presentation Investor relations Beat · DevelopmentLoop · Cost Of Inaction1 hit
06
The chart uses an indexed scale where the average of other states is 1.0x.DraftKings | Results Presentation Deck | 12 slides · DraftKings
Conference presentation Investor relations Beat · DevelopmentLoop · Cost Of Inaction1 hit
05
The slide uses a horizontal process flow with numbered star-shaped markers.Hydrafacial | Investor Presentation Deck | 9 slides · BeautyHealth
Conference presentation Investor relations Beat · Rising Success1 hit
06
The slide uses a photo-grid layout to demonstrate brand presence and infrastructure.Hydrafacial | Investor Presentation Deck | 9 slides · BeautyHealth
Conference presentation Investor relations Beat · Rising Success1 hit
06
The slide uses a before-after framework to contrast the focus areas of two clinical trial phases, followed by a numbered list of specific improvements.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
07
The slide uses a process-flow layout to show progression from Phase 1a to 1b to final takeaways.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
08
Includes footnotes defining abbreviations and trial parameters.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
05
The slide uses color coding to distinguish between Oncology (dark blue) and Immunology-Inflammation (orange) programs.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
06
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
07
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
08
Includes a table of prevalence/incidence for specific indications and a biological pathway diagram.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
09
The slide uses a dual-panel layout: left shows tumor volume reduction over time with weekly dosing; right shows PK/PD relationship highlighting the 48-hour window of STAT3 knockdown.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
10
The slide uses a process flow diagram to illustrate the transition from dose escalation to expansion cohorts.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
04
The slide uses a target icon to visually represent the 'objective' concept.Larimar Therapeutics | Results Presentation Deck | 15 slides · Larimar Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
05
Larimar Therapeutics | Results Presentation Deck | 15 slidesLarimar Therapeutics | Results Presentation Deck | 15 slides · Larimar Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
Standard financial statement presentation.Nikola | Results Presentation Deck | 20 slides · Nikola
Conference presentation Investor relations Beat · DevelopmentLoop · Cost Of Inaction1 hit
15
Includes footnotes explaining the basis of the projections and specific inclusions like Romeo-related costs.Nikola | Results Presentation Deck | 20 slides · Nikola
Conference presentation Investor relations Beat · DevelopmentLoop · Cost Of Inaction1 hit
06
The slide uses anatomical diagrams to illustrate the spread of alpha-synuclein (labeled 'α') across the nervous system for three different neurodegenerative conditions.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit